Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Robert-Rössle-Klinik is a specialized oncological center located in Berlin-Buch, Germany, renowned for its comprehensive cancer care and translational research. Founded in 1949 and named after the prominent pathologist Robert Rössle, the clinic has a long-standing history of bridging the gap between laboratory research and clinical application. It currently operates as a core component of the Helios Klinikum Berlin-Buch, part of the Helios Kliniken group, and maintains a strategic partnership with the Max Delbrück Center for Molecular Medicine (MDC). The facility offers advanced treatments in surgical oncology, medical oncology, and radiation therapy, serving as a major hub for clinical trials in Europe. Its multidisciplinary approach ensures that patients receive personalized care based on the latest scientific findings in genomics and immunotherapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Robert-Rössle-Klinik.